“REMOTE AND VIRTUAL INSPECTIONS DURING THE COVID-19 PANDEMIC: REGULATOR PERSPECTIVES” – STILL TIME TO REGISTER!
Globally, the COVID-19 pandemic has required changes in the way regulators worldwide have been approaching the inspection of manufacturing facilities. Please join us for a webinar presented by PDA sponsored by Lachman Consultants titled “Remote and Virtual Inspections during the COVID-19 Pandemic: Regulator Perspectives” on June 29 from 10 am-11:30 AM EST to gain some […]
Recording available for webinar on Virtual Inspections
Lachman Consultants recently participated in a webinar with Arnold & Porter called “FDA Inspection Alternatives During the COVID-19 Pandemic: Requesting, Preparing for and Responding to FDA Virtual Inspections”. If you missed it, don’t despair – there is a recording of it, which can be found here. We hope you enjoy it, and look forward to “seeing” you at […]
Lachman Consultants to Sponsor PDA Webinar “Remote and Virtual Inspections during the COVID-19 Pandemic: Regulator Perspectives”
Globally, the COVID-19 pandemic has required changes in the way regulators worldwide have been approaching the inspection of manufacturing facilities. Please join us for a webinar presented by PDA sponsored by Lachman Consultants titled “Remote and Virtual Inspections during the COVID-19 Pandemic: Regulator Perspectives” on June 29 from 10 am-11:30 AM EST to gain some […]
WEBINAR: FDA Inspection Alternatives During the COVID-19 Pandemic: Requesting, Preparing for and Responding to FDA Virtual Inspections
Due to COVID-19 travel and safety concerns, the Food and Drug Administration has suspended most of its foreign and domestic inspections. In order to avoid delays in evaluating applications to market drugs, devices and biologics because of the lack of an in-person inspection, FDA has recognized the need to rely on alternatives, such as virtual […]
WEBINAR: FDA Inspection Alternatives During the COVID-19 Pandemic: Requesting, Preparing for and Responding to FDA Virtual Inspections
Due to COVID-19 travel and safety concerns, the Food and Drug Administration has suspended most of its foreign and domestic inspections. In order to avoid delays in evaluating applications to market drugs, devices and biologics because of the lack of an in-person inspection, FDA has recognized the need to rely on alternatives, such as virtual […]
New Webinar Series From Lachman Consultants Provides Valuable Information To The Pharmaceutical Industry
(Westbury, NY— April 2019) Lachman Consultant Services, Inc. (Lachman Consultants) will be launching a new webinar series beginning with “Preparing for and Handling an FDA Inspection” on Thursday, May 14th at 2:00 pm EDT. Ever a responsive and supportive partner to its clients, these webinars are Lachman Consultants latest effort in providing timely and critical […]
Lachman Consultants Offers Support to Help U.S. Distilleries and Breweries Manufacture Hand Sanitizer
(Westbury, NY – April 6, 2020) For industries not accustomed to working with the FDA or interpreting FDA regulations and guidance in the manufacture of hand sanitizers, this can be a challenging time. In support of these companies’ efforts to aid in stemming the advance of COVID-19, Lachman Consultant Services, Inc. (“Lachman Consultants”) is reaching […]
Coronavirus Readiness
As the impact of the Coronavirus (COVID-19) is being felt throughout the United States and around the world, Lachman Consultants is reaching out to inform our valued clients and partners regarding the actions taken by our organization. Our continuing goal is to best safeguard the health and safety of our people, those within your […]
Scott Deckebach, M.B.A., new Director in the Compliance Practice at Lachman Consultant Services, Inc.
We are pleased to announce that Scott Deckebach has accepted the position of Director in the Compliance Practice at Lachman Consultants, effective January 27, 2020. Mr. Deckebach is a life sciences and medical device regulatory compliance, manufacturing, and technology expert with more than 25 years of experience in the industry. Mr. Deckebach has been affiliated […]
John Darby, new Senior Director in the Compliance practice at Lachman Consultant Services, Inc.
We are pleased to announce that John Darby has accepted the position of Senior Director at Lachman Consultants, effective December 2, 2019. Mr. Darby is a goal directed, results-focused executive professional with a strong, global background in quality assurance, compliance, audits, training, and remediation. His 18 years of experience and keen insight contribute to his […]